Terms: = Thyroid cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Treatment
6 results:
1. GSK2801 Reverses Paclitaxel Resistance in Anaplastic thyroid cancer Cell Lines through mycn Downregulation.
Molteni E; Baldan F; Damante G; Allegri L
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983070
[TBL] [Abstract] [Full Text] [Related]
2. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
3. UNC5B-AS1 promoted ovarian cancer progression by regulating the H3K27me on NDRG2 via EZH2.
Wang H; Su H; Tan Y
Cell Biol Int; 2020 Apr; 44(4):1028-1036. PubMed ID: 31903696
[TBL] [Abstract] [Full Text] [Related]
4. Identification of novel biomarker and therapeutic target candidates for diagnosis and treatment of follicular carcinoma.
Lai X; Umbricht CB; Fisher K; Bishop J; Shi Q; Chen S
J Proteomics; 2017 Aug; 166():59-67. PubMed ID: 28709933
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of NDRG2 Increases Iodine Uptake and Inhibits thyroid Carcinoma Cell Growth In Situ and In Vivo.
Yin A; Wang C; Sun J; Gao J; Tao L; Du X; Zhao H; Yang J; Li Y
Oncol Res; 2016 Jan; 23(1-2):43-51. PubMed ID: 26802650
[TBL] [Abstract] [Full Text] [Related]
6. Cervical neuroblastoma and multiple endocrine neoplasia type 2a.
Triglia JM; Bernard JL; Scheiner C
Int J Pediatr Otorhinolaryngol; 1993 Feb; 26(1):71-7. PubMed ID: 8095252
[TBL] [Abstract] [Full Text] [Related]
